Açıklama
In vitro drug release profile of quercetin from chitosan nanoparticles under simulated nasal conditions, demonstrating sustained release characteristics compared to free quercetin.
Figure 3
ChartSource Paper
Quercetin-crosslinked chitosan nanoparticles: a potential treatment for allergic rhinitis.Cite This Figure
![Figure 3: In vitro drug release profile of quercetin from chitosan nanoparticles under simulated nasal conditions, demonstrating sustained release characteristics compared to free quercetin.]() > Source: Dehong Mu et al. "Quercetin-crosslinked chitosan nanoparticles: a potential treatment for allergic." *Scientific reports*, 2024. PMID: [38369554](https://pubmed.ncbi.nlm.nih.gov/38369554/)
<figure> <img src="" alt="In vitro drug release profile of quercetin from chitosan nanoparticles under simulated nasal conditions, demonstrating sustained release characteristics compared to free quercetin." /> <figcaption>Figure 3. In vitro drug release profile of quercetin from chitosan nanoparticles under simulated nasal conditions, demonstrating sustained release characteristics compared to free quercetin.<br> Source: Dehong Mu et al. "Quercetin-crosslinked chitosan nanoparticles: a potential treatment for allergic." <em>Scientific reports</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38369554/">38369554</a></figcaption> </figure>